← Every applicant
Hospira FDA Approvals
10 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| POTASSIUM PHOSPHATESNew drugSep 11, 2025SOLUTION, INTRAVENOUS |
| BENDAMUSTINE HYDROCHLORIDENew drugDec 15, 2022SOLUTION, INTRAVENOUS |
| REGADENOSONNew drugAug 31, 2022SOLUTION, INTRAVENOUS |
| BORTEZOMIBNew drugJul 26, 2022INJECTABLE, INTRAVENOUS, SUBCUTANEOUS |
| PEMETREXED DISODIUMNew drugJun 22, 2022SOLUTION, INTRAVENOUS |
| PEMETREXED DITROMETHAMINENew drugJun 10, 2022POWDER, INTRAVENOUS |
| PEMETREXED DISODIUMNew drugMay 25, 2022POWDER, INTRAVENOUS |
| BORTEZOMIBNew drugMay 2, 2022POWDER, INTRAVENOUS, SUBCUTANEOUS |
| AZTREONAMNew drugNov 8, 2021INJECTABLE, INJECTION |
| DAPTOMYCINNew drugJun 21, 2021POWDER, INTRAVENOUS |